Project Farma acquires SimoTech to expand GMP automation and digital manufacturing capabilities

The acquisition adds SimoTech’s automation engineering and digital manufacturing expertise to Project Farma’s existing life sciences manufacturing services, creating a broader offering spanning facility strategy through GMP operations.

Project Farma, a PerkinElmer company, has acquired SimoTech, a specialist in automation, digital manufacturing and engineering services for the life sciences industry, with financial terms not disclosed.

The acquisition expands Project Farma’s ability to support pharmaceutical and biotechnology manufacturers across automation strategy, system implementation, commissioning and ongoing GMP operations.

Field	Content
Alert Type	Deal
Companies	Project Farma; PerkinElmer; SimoTech
Deal Type	Acquisition
Asset or Company	SimoTech
Technology or Modality	GMP automation; digital manufacturing; manufacturing execution systems; process control and engineering services
Deal Value	Financial terms have not been disclosed.
Geography	United States; Ireland; global life sciences markets
What Happened	Project Farma, part of PerkinElmer’s OneSource Life Sciences business, has acquired SimoTech, an engineering company specialising in automation and digital manufacturing for pharmaceutical and biotechnology customers. The acquisition combines SimoTech’s expertise in areas including automation, manufacturing execution systems, digitalisation and GMP manufacturing systems with Project Farma’s existing capabilities across manufacturing strategy, capital projects, facility builds, technology transfer, commissioning, qualification and validation. Financial terms were not disclosed.
Why It Matters	Automation and connected manufacturing systems are increasingly integral to the design, commissioning and operation of GMP facilities. Adding SimoTech enables Project Farma to offer customers a more integrated service spanning physical manufacturing infrastructure and the automation and digital systems required to operate it, reducing the need to coordinate these capabilities across separate providers. Project Farma already provides automation, controls and validation services as part of its manufacturing offering. (Project Farma)
Supporting Context	Project Farma provides manufacturing and technical-operations consulting across biologics and advanced modalities, with more than 1,600 employees supporting projects in North America, Europe and Asia-Pacific. Its existing services cover the manufacturing lifecycle from strategy and facility construction through automation, validation, operational readiness and asset lifecycle management. (Project Farma)
Strategic Rationale	Project Farma gains SimoTech’s specialist automation and digital-manufacturing workforce and capabilities, complementing its existing facility, engineering, validation and technical-operations services. The combination is intended to provide life sciences customers with more continuous support from manufacturing strategy and facility development through automation implementation and GMP operations.
Potential Impact	The acquisition could increase Project Farma’s ability to compete for life sciences manufacturing programmes requiring integrated facility, automation and digital delivery, particularly as pharmaceutical manufacturers invest in connected and increasingly automated production environments. The commercial impact has not been disclosed.
Key Takeaway	Acquiring SimoTech expands Project Farma’s manufacturing offering deeper into GMP automation and digital systems, creating a more integrated technical-operations platform for pharmaceutical and biotechnology customers.
What to Watch	Integration of SimoTech into Project Farma and PerkinElmer’s OneSource Life Sciences organisation, including how its automation and digital manufacturing capabilities are deployed across Project Farma’s global customer base.
Primary Source	Press release issued by PerkinElmer/Project Farma: https://pressreleasehub.pa.media/article/project-farma-acquires-simotech-bringing-end-to-end-gmp-automation-and-digital-manufacturing-to-life-sciences-customers-80775.html
Relevant Date	August 2026

---

Discover how nuaxia can support your next medical education initiative:

• Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector 

• Contact us on: support@nuaxia.com